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Cytotoxic T Lymphocyte Antigen-4 Accumulation
in the Immunological Synapse Is Regulated
by TCR Signal Strength
the ability to bind B7 family members with its homolog
cytotoxic T lymphocyte antigen 4 (CTLA-4). However,
B7 binds to CTLA-4 with up to 2500-fold higher avidity
than to CD28 (Greene et al., 1996; van der Merwe et al.,
1997). Upon ligation to B7, CD28 and CTLA-4 deliver
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Berkeley, California 94720 opposing signals for T cell activation, with CD28 gener-
ating an activating costimulatory signal and CTLA-4
functioning to inhibit the response (Thompson and Alli-
son, 1997). CD28 ligation enhances T cell proliferationSummary
through multiple mechanisms, including increased pro-
duction and stability of IL-2 mRNA (Lindsten et al., 1989)CD28 and CTLA-4 engagement with B7 expressed by
APCs generates critical regulatory signals for T cell and upregulation of anti-apoptotic genes, such as Bcl-XL
(Boise et al., 1995). In contrast, CTLA-4 signaling re-activation. CD28 is expressed on the T cell surface
and enhances T cell expansion, while CTLA-4 localizes duces the production of both the growth factor IL-2
(Walunas et al., 1994; Krummel and Allison, 1995) andprimarily to an intracellular compartment and inhibits
T cell proliferation. We demonstrate that CTLA-4 has cyclin D3, cyclin-dependent kinase (cdk)4, and cdk6
(Brunner et al., 1999), thus restricting T cell expansion.several unique trafficking properties that may regulate
its ability to attenuate a T cell response. Importantly, The activation of a T cell is thus dictated by the integra-
tion of signals derived from the TCR, CD28, and CTLA-4.accumulation of CTLA-4 at the immunological synapse
is proportional to the strength of the TCR signal, sug- By regulating the expansion of individual T cells, CD28
and CTLA-4 could modulate the composition of a poly-gesting that cells receiving stronger stimuli are more
susceptible to CTLA-4-mediated inhibition. This may clonal antigen-specific T cell response.
Protein trafficking has long been recognized as anrepresent a novel feedback control mechanism in which
a stimulatory signal regulates the recruitment of an important factor influencing T cell activation. Early work
demonstrating cytoskeletal reorganization and proteininhibitory receptor to a functionally relevant site on
the cell surface. polarization in response to stimulation has been funda-
mental in understanding TCR-mediated signal transduc-
tion (Kupfer and Singer, 1989). More recent studies haveIntroduction
continued to yield insight into the spatial and temporal
localization of proteins during T cell interactions withThe enormous complexity of the T cell antigen receptor
(TCR) repertoire provides the immune system with the APCs. Collectively, this work has led to the concept of
an immunological synapse (Bromley et al., 2001). Thiscapacity to recognize a vast array of antigens. The T cell
response to any given antigen involves the selective structure is thought to be essential for the generation
and maintenance of signals that determine the fate ofclonal expansion of a small number of T cells that share
specificity but express unique TCRs. Thus, the overall a T cell upon antigenic stimulation. Despite the impor-
tance of CD28 and CTLA-4 in regulating T cell activation,response is shaped by factors that regulate the expan-
sion of individual T cells upon activation. the factors that influence their localization to the immu-
nological synapse remain only partially characterized.T cell activation is a dynamic process, involving the
interaction of several key T cell surface proteins with CD28 and CTLA-4 expression and localization during
T cell encounters with APCs may be critical factors inspecific ligands on the surface of antigen-presenting
cells (APCs). The integration of signals generated by determining when and how these proteins act to modu-
late a T cell response.these interactions determines the final outcome of en-
counters between T cells and APCs. A critical require- While CD28 and CTLA-4 are homologs, they display
markedly different patterns of expression and localiza-ment for T cell activation is the engagement of TCRs
with major histocompatibility complex (MHC) molecules tion. Both naive and activated T cells constitutively ex-
presenting antigenic peptides on the surface of an APC press CD28 (Gross et al., 1990). In contrast, CTLA-4 is
(Davis and Bjorkman, 1988). Importantly, this interaction not detectable at the protein level in naive cells but is
does not represent a simple on/off switch, as the TCR upregulated upon T cell activation (Lindsten et al., 1993).
is capable of sensing subtle changes in its ligand to In addition, CD28 localizes to the plasma membrane,
produce a range of distinct biological responses (Kersh whereas a tyrosine-based intracellular localization motif
and Allen, 1996). targets CTLA-4 to the endosomal compartment via an
While TCR-peptide/MHC signals are necessary for association between its intracellular tail and the medium
T cell activation, they are generally not sufficient and a chain of the clathrin coated pit adaptor protein AP-2
second distinct signal is required. The primary source (Bradshaw et al., 1997; Chuang et al., 1997; Shiratori et
of this costimulatory signal is generated by interactions al., 1997; Zhang and Allison, 1997). Mutation or phos-
between the T cell integral membrane protein CD28 and phorylation of this tyrosine prevents AP-2 binding, re-
its ligands, B7-1 and B7-2, on the APC. CD28 shares sulting in increased surface expression of CTLA-4
(Leung et al., 1995; Bradshaw et al., 1997; Shiratori et
al., 1997). Thus, surface expression of CTLA-4 is highly1 Correspondence: jallison@uclink4.berkeley.edu
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Figure 1. Localization of CD28 and CTLA-4
in Migrating T Cells
T cells isolated from a 5C.C7 TCR transgenic
Rag/ mouse were stimulated for 5 days with
irradiated syngenic spleenocytes pulsed with
MCC agonist peptide. Cells were stained
with antibodies specific for tubulin and (A)
CD28 or (B) CTLA-4. The color overlay images
shows tubulin in green, CD28 or CTLA-4 in
red, and a nuclear stain in blue. Images were
acquired using a 63 objective.
restricted, suggesting a potential regulatory point for conditions of stronger TCR stimulation, suggesting that
CTLA-4 preferentially inhibits the T cell response undercontrolling its inhibitory function.
Trafficking of CD28 and CTLA-4 occurs in the context conditions of more potent TCR signaling. These findings
have broad implications for the roles of CTLA-4 andof the general cytoskeletal rearrangements that tran-
spire in T cells upon stimulation. These include reorien- CD28 in regulating the T cell response to antigen.
tation of the microtubule organizing center (MTOC) to
a position facing the APC contact site, localized actin Results
polymerization, and accumulation of proteins at the
T cell-APC interface (Kupfer and Singer, 1989). CD28 is Localization Patterns of CTLA-4 and CD28
in Activated T Cellsthought to cluster in the same region as the TCR at the
immunological synapse (Grakoui et al., 1999). Addition- T cells undergo a dramatic morphological transformation
upon activation, eventually acquiring the phenotype of aally, upon ligation with antibody, CD28 has been shown
to undergo PI3-kinase-dependent endocytosis, sug- migrating lymphocyte. Migrating lymphocytes are charac-
terized by two main structures, a leading edge and agesting that internalization may occur during normal
T cell-APC interactions (Cefai et al., 1998). The expres- uropod. The leading edge of a T cell is the site of lamello-
podia and filopodia formation, resulting in polarized lo-sion pattern and intracellular localization of CTLA-4 has
made it more difficult to study. Previous work has dem- comotion. The uropod of the T cell is a pseudopod-like
projection at the tail end of the cell that usually containsonstrated that the majority of intracellular CTLA-4 within
an activated T cell polarizes toward the site of TCR the MTOC (Sanchez-Madrid and del Pozo, 1999).
Knowing that CTLA-4 expression is induced upon TCRengagement (Linsley et al., 1996). This polarization is
likely related to the rapid reorientation of the T cell MTOC stimulation, we were interested in determining the local-
ization patterns of CTLA-4 in the context of an activatedtoward APCs bearing antigenic peptide/MHC com-
plexes (Kupfer et al., 1987). While polarization of CTLA-4 T cell and comparing this localization to that of CD28.
Determining the localization of CD28 and CTLA-4 in aoccurs when a T cell receives a stimulatory signal, it
has remained unclear whether this polarization is ac- T cell before interactions with an APC is important for
understanding how spatial constraints could influencecompanied by its expression on the cell surface at the
immunological synapse. the ability of these proteins to regulate a T cell response.
T cells from 5C.C7 TCR transgenic mice were stimulatedThe balance between activating signals generated by
CD28 and inhibitory signals delivered by CTLA-4 can with irradiated syngeneic spleenocytes pulsed with an
agonist peptide consisting of amino acid residues 88 todetermine the outcome of a T cell’s interaction with an
APC. Protein localization provides one way of regulating 103 of the moth cytochrome C protein (MCC). Activated
T cells were subsequently fixed, permeablized, andthis balance. We investigated the trafficking characteris-
tics of CTLA-4 and CD28 in order to gain insight into both stained with antibodies specific for CTLA-4 and CD28.
CD28 was found to be evenly distributed throughout thehow and when these molecules exert their regulatory
function on T cell activation. CTLA-4 expression levels plasma membrane of the T cell (Figure 1A). In contrast,
CTLA-4 was primarily found near the MTOC and in thewere found to be highly regulated by a short protein half-
life. Upon antigen-specific interactions of a T cell with an uropod (Figure 1B). Thus, while CD28 was present at
the leading edge of the T cell, CTLA-4 appeared to beAPC, CTLA-4 reorganizes to a site facing the antigenic
stimulus, where it is then in a position to translocate to sequestered in an intracellular compartment facing
away from this site. Given the finding that T cell activa-the T cell-APC interface. Importantly, localization of
CTLA-4 to the immunological synapse is favored under tion generally occurs through interactions between a
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T cell’s leading edge and an APC (Negulescu et al.,
1996), this pattern of localization could be important in
determining the kinetics of signaling by these proteins.
CD28 would be in a position to quickly interact with B7
molecules during the initial contact of a T cell with an
APC, while CTLA-4 localization to the cell interface
would be slower due to a dependence on TCR-mediated
cytoskeletal reorganization.
Rapid Turnover of CTLA-4
We sought to determine the turnover rate for CD28 and
CTLA-4 protein in order to better understand how tran-
scriptional and/or translational regulation of new protein
synthesis could impact the ability of these proteins to
modulate the T cell response. Previously published studies
have demonstrated that at least some fraction of CTLA-4
is in the lysosomal compartment (Oki et al., 1999;
Schneider et al., 1999). In addition, recent experiments
have shown that levels of exogenously introduced
CTLA-4 are sensitive to inhibition of protein synthesis
and lysosomal degradation in transfected T cell clones
(Iida et al., 2000). However, the rate of endogenous pro-
tein turnover has not been established. Turnover rate
clearly has important consequences for the regulation
of CTLA-4 and CD28 signals during T cell activation.
Activated T cells were treated with cycloheximide to
inhibit protein translation and subsequently analyzed
for total CD28 and CTLA-4 levels by flow cytometry at
varying time points. Expression of transferrin receptor,
a protein known to recycle between surface and endoso-
mal compartments, was also monitored. While both
transferrin receptor (Figure 2A) and CD28 (Figure 2B)
levels remained relatively constant throughout the
course of the experiment, we found that CTLA-4 levels
rapidly decreased in the absence of new protein transla-
tion (Figure 2C). Inhibition of lysosomal degradation by
treating cells with either ammonium chloride or chlo-
roquine (data not shown) led to accumulation of CTLA-4
protein within T cells and slowed the rate of cyclohexi-
mide-induced decrease in CTLA-4 expression, but had
little effect on either transferrin receptor or CD28 levels
(Figure 2). The rapid turnover rate of CTLA-4 ensures
that the level of protein expression within the cell is
closely linked to the rate of gene transcription and/or
translation.
Antigen-Induced Localization of CD28 and CTLA-4
to the T Cell-APC Interface
Having determined the expression and localization char-
acteristics of CTLA-4 and CD28 in activated migrating
T cells, we were interested in observing the trafficking
of these proteins upon the T cell’s encounter with APCs
bearing antigenic peptides. We therefore analyzed
T cell-APC conjugates by fluorescence microscopy. Ac-
tivated 5C.C7 TCR transgenic T cells were incubated
for 1 hr with APCs that had been pulsed with either an
Figure 2. CTLA-4 Has a Rapid Rate of Protein Turnover were washed and a total of 30,000 events were analyzed by flow
Activated 5C.C7 TCR transgenic T cells were treated with cyclohexi- cytometry. Y-axis values were obtained by dividing the background
mide (15g/ml) and/or ammonium chloride (20 mM). At the indicated subtracted MFI values at the indicated time points by the back-
time points, cells were permeabilized and stained with antibodies ground subtracted MFI values at time  0. Data are representative
specific for (A) transferrin receptor, (B) CD28, or (C) CTLA-4. Cells of three similar experiments.
Figure 3. TCR Signaling-Induced Translocation of PKC, CD28, and CTLA-4 to the T Cell-APC Interface
(A–C) Activated 5C.C7 TCR transgenic T cells were mixed at a 1:1 ratio with CH12.LX B cells that had been pulsed with 10 M of either the
agonist peptide MCC88-103 or the control peptide HB64-76. Cells were allowed to interact for 1 hr. Cell conjugates were processed as described
in the Experimental Procedures and stained with antibodies specific for tubulin and (A) PKC, (B) CD28, or (C) CTLA-4. The color overlay
images shows tubulin in green, CD28, CTLA-4, or PKC in red, and a nuclear stain in blue. Images were acquired using a 63 objective.
(D) Cells were processed as above except stained with antibodies specific for PKC and (left) CD28 or (right) CTLA-4. The color overlay
images shows PKC in green, CD28 or CTLA-4 in red, and a nuclear stain in blue. Areas of CD28 or CTLA-4 overlap with PKC are yellow.
Images were acquired using a 100 objective. T cells are in the upper half of all images.
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Figure 4. Rapid Polarization of CD28 and CTLA-4 to the T Cell-APC Interface
(A) CD28 or (B) CTLA-4 GFP fusion protein constructs were introduced into activated 5C.C7 TCR transgenic T cells using retroviral infection.
Three to four days postinfection, cells were used for live cell fluorescence microscopy experiments as described in the Experimental Procedures.
The upper panels show GFP fluorescence as a monochrome image. The lower panels are an overlay of a brightfield image of the cells and
GFP fluorescence displayed as a pseudocolor intensity image (red, higher intensity; green, lower intensity). Movies of this data can be found
online as Supplemental Movie S1 (http://www.immunity.com/cgi/content/full/16/1/23/DC1) and Supplemental Movie S2 (http://www.immunity. com/
chi/content/full/16/1/23/CD1).
irrelevant I-Ek binding peptide derived from hemoglobin In order to better localize this population, we performed
costains of CTLA-4 with molecules known to be associ-(HB) or the agonist MCC peptide. APCs pulsed with HB
failed to induce localization of PKC, CD28, or CTLA-4 ated with the T cell plasma membrane. Both CD28 and
CTLA-4 staining clearly overlapped with PKC (Figureto the T cell-APC interface (Figure 3). In addition, the
T cell MTOC did not reorganize toward a site facing the 3D) and CD3  (data not shown), suggesting that this
population of CTLA-4 was on the surface of the T cellAPC, consistent with previously published data (Kupfer
et al., 1987). Importantly, stimulation with the MCC pep- at the immunological synapse. This pattern of CTLA-4
localization suggests that accumulation of CTLA-4 attide induced both MTOC reorientation and a clear accu-
mulation of PKC, CD28, and CTLA-4 at the T cell-APC the T cell-APC interface may be independent of its polar-
ization. Regulating the translocation of polarized intra-interface. Consistent with previous studies (Monks et
al., 1997), PKC was clustered at the central region of cellular CTLA-4 to the T cell surface may provide a mech-
anism to govern CTLA-4-mediated inhibition duringthe synapse as a result of antigenic stimulation (Figure
3A). Additionally, while CD28 was detected on the entire T cell-APC interactions.
surface of the T cell, staining was also most concen-
trated at the center of the interface (Figure 3B). Kinetics of CTLA-4 and CD28 Localization to the T Cell-
APC Interface upon Encounter with an APC BearingAntigen-dependent polarization of intracellular CTLA-4
to a site facing T cell contact with APC was expected Antigenic Peptide/MHC Complexes
Previously published studies have demonstrated polar-(Linsley et al., 1996). However, in addition to this intracel-
lular population, there was also an accumulation of ization of CTLA-4 occurring within 3 hr after TCR stimula-
tion (Linsley et al., 1996). The above results demonstrateCTLA-4 at a site that appeared to be on the surface of
the T cell at the contact site with the APC (Figure 3C). that this polarization can occur within 1 hr after antigen-
Immunity
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Figure 5. Effect of Differing TCR Signal Strengths on IL-2 Production, T Cell-APC Conjugate Formation, and T Cell MTOC Reorientation
(A) T cells were cocultured at a 1:1 ratio with APCs in the presence of varying concentrations of the indicated peptides. After a 12 hr incubation,
supernatants were collected and analyzed for IL-2 content by ELISA. Data points represent the mean of triplicate wells. Error bars represent
the standard deviation. Data are representative of three similar experiments.
(B) T cells and APCs were labeled with CFSE and PK-H26, respectively. APCs cells were pulsed with varying concentrations of the indicated
peptides and subsequently mixed with T cells at a 1:1 ratio. After a 1 hr incubation, cell conjugates were quantified using flow cytometry as
described in the Experimental Procedures. Data are representative of three similar experiments.
(C) APCs were pulsed with the indicated peptides and mixed at a 1:1 ratio with T cells. After a 1 hr incubation, cells were processed and
scored for MTOC reorientation as described in the Experimental Procedures. Open circles represent values from individual experiments and
closed circles represent the average of these values. All experiments were performed blind.
specific T cell-APC interactions. In order to further ex- within the T cell uropod. Upon contact of the T cell
with an antigenic peptide pulsed APC, both GFP fusionamine the kinetics of CTLA-4 polarization, and relate
these findings to the trafficking of CD28, green fluores- proteins rapidly localized to the site of cell-cell contact.
CD28GFP fluorescence began to increase at the T cell-cent protein (GFP)-tagged molecules were retrovirally
expressed in in vitro stimulated primary T cells derived APC interface almost instantaneously (Figure 4A).
CTLA-4GFP rapidly polarized toward the T cell-APC in-from 5C.C7 TCR transgenic mice. Infected T cells were
examined using time-lapse microscopy in order to track terface, transiting from the back of the cell to the contact
site (Figure 4B). The polarization of CTLA-4 from thethe movement of the CD28-GFP and CTLA-4-GFP during
antigen-specific T cell-APC interactions. uropod of the T cell to the site of contact with APC is
likely representative of the kinetics of MTOC reorienta-Consistent with the results from antibody staining of
fixed cells, CD28GFP was primarily localized to the T cell tion to a position facing the TCR stimulus (Kupfer et al.,
1987). These data demonstrate that trafficking of bothsurface, while CTLA-4GFP was localized intracellularly
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CD28 and CTLA-4 is highly responsive to TCR stimula-
tion. Additionally, CTLA-4 rapidly localizes to a position
where it could traffic from an intracellular compartment
to the T cell-APC interface.
Reduced IL-2 Production, Conjugate Formation,
and CTLA-4 Surface Expression in Response
to Weak Agonist Peptides
Because of the staining pattern of CTLA-4, we reasoned
that translocation of polarized, intracellular CTLA-4 to
the T cell-APC contact site may be a regulatory point
for controlling the contribution of its inhibitory signal to
the process of T cell activation. TCR signal strength is
known to affect protein trafficking to the site of TCR
engagement (Monks et al., 1998; Grakoui et al., 1999;
Huang et al., 2000; Krummel et al., 2000). Therefore, we
reasoned that TCR signal strength could differentially
affect the translocation of CTLA-4 and CD28 to the im-
munological synapse. In order to examine the depen-
dence of CTLA-4 and CD28 protein trafficking on TCR
signal strength, we utilized a set of altered peptides that
elicited decreased T cell responses compared to MCC.
Previous work identified a series of MCC peptide vari-
ants that, while binding to the MHC class II molecule I-Ek
with similar affinity, had reduced capacity to stimulate a
T cell response (Reay et al., 1994). We screened several
of these peptides for their ability to induce conjugate
formation and IL-2 production by previously activated
5C.C7 TCR transgenic T cells. We found two peptides
(T102S and T102N) that consistently yielded reduced
levels of IL-2 production (Figure 5A) and conjugate for-
mation (Figure 5B) when compared to MCC. These pep-
tides have been previously characterized as weak ago-
nists for the 2B4 TCR, which, like the 5C.C7 TCR, binds
to MCC presented by I-Ek. The reduced stimulatory ac-
tivity of these peptides has been attributed to a faster
disassociation rate of a weak agonist peptide/MHC
complex from the 2B4 TCR (Davis et al., 1998). A similar
mechanism likely accounts for the reduced biological
response of 5C.C7 T cells to the T102S and T102N weak
agonist peptides (Savage et al., 1999). We also identified
one peptide (Y97F) that induced higher levels of IL-2 Figure 6. Weak Agonist Peptides Induce Reduced CTLA-4 Surface
production and a similar degree of conjugate formation Expression in the Absence of an Effect on Total Protein Levels
compared to MCC (Figures 5A and 5B). Thus we had T cells were mixed at a 1:1 ratio with peptide pulsed APCs and
two agonist peptides (MCC and Y97F) and two weak subsequently analyzed for CTLA-4 surface expression as described
in the Experimental Procedures. (A) Surface expression of CTLA-4agonist peptides (T102S and T102N) with which to per-
was measured by staining cells with antibodies specific for CTLA-4form studies.
or an isotype control antibody. (B) Total levels of CTLA-4 wereWe used these peptides to compare the effect of TCR
measured by staining permeabilized cells with an antibody specific
signal strength on the induction of CTLA-4 surface ex- for CTLA-4 or an isotype control antibody. Staining was performed
pression. Naive 5C.C7 TCR transgenic T cells were stim- as described in the Experimental Procedures. Each cell sample was
ulated with MCC peptide, expanded, and restimulated stained in triplicate and data points represent the average mean
fluorescence intensity values. Error bars represent the standardfor 1 hr with APCs that had been pulsed with one of five
deviation. Data are representative of three similar experiments.different peptides. 10 M of peptide was used because
at this concentration all peptides induced a similar de-
gree of conjugate formation. Thus, analysis of CTLA-4
surface expression would not be skewed due to differing lated with agonist peptides had a small but reproducible
increase in CTLA-4 surface expression compared withfrequencies of T cell-APC conjugates.
Analysis using flow cytometry revealed a stimulation- cells stimulated with weak agonist peptides (Figure 6A).
This increased induction of surface CTLA-4 occurred independent increase in the cell surface expression of
CTLA-4, as both agonist and weak agonist peptides the absence of an increase in its protein synthesis, as
staining of permeablized cells stimulated with the differ-induced a greater specific fluorescence intensity com-
pared to the basal level of CTLA-4 expressed by cells ent peptides revealed no significant change in the levels
of total cellular CTLA-4 (Figure 6B). These results sug-stimulated with a null peptide. Importantly, cells stimu-
Immunity
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Figure 7. Differential Translocation of CTLA-4 to the T Cell-APC Interface Is Dependent on TCR Signal Strength
(A–C) Activated 5C.C7 TCR transgenic T cells were mixed at a 1:1 ratio with CH12.LX B cells that had been pulsed with 10 M of either an
agonist peptide (MCC or Y97F) or a weak agonist peptide (T102S or T102N). Cells were processed as in Figure 3 and stained with antibodies
specific for tubulin and (A) PKC, (B) CD28, or (C) CTLA-4. The color overlay images shows tubulin in green, CD28, CTLA-4, or PKC in red,
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gest that expression of CTLA-4 on the T cell surface is pressed detectable levels of PKC, CD28, or CTLA-4
were included in the analysis. Using this method to com-proportional to the intensity of the TCR signal.
pare the frequency of protein translocation induced by
weak agonist versus agonist peptides, we found that aDifferential Translocation of CTLA-4 to the T Cell-APC
Interface Depends on TCR Signal Quality higher frequency of cells accumulated CTLA-4 at the
T cell-APC interface when the T cells received strongerTo further determine the relationship between TCR sig-
nal quality and protein trafficking, fluorescence micros- TCR signals. This difference was not observed for either
PKC or CD28. Importantly, differences in CTLA-4 local-copy was utilized to examine the localization of PKC,
CD28, and CTLA-4 in response to TCR signals generated ization occurred in the absence of an increase in total
expression levels (Figure 5D), suggesting that CTLA-4by the different peptides. Stimulation of T cells with
APCs pulsed with 10 M of an agonist peptide resulted translocation is regulated by a posttranslational mecha-
nism. Therefore, localization of CTLA-4 at the immuno-in the localization of PKC, CD28, and CTLA-4 to the
T cell-APC interface, similar to data shown in Figure 3 logical synapse can occur independently of its polariza-
tion to a site facing the T cell-APC interface. TCR signalsusing the MCC peptide. Both agonist peptides and weak
agonist peptides were equally capable of inducing are required for both of these events to occur. However,
the strength of the TCR signals determines the extentMTOC reorientation (Figure 5C), consistent with the
equivalent levels of conjugate formation observed at of CTLA-4 surface expression. This localization property
is not shared with either PKC or CD28 and appears tothis concentration of peptide. Additionally, neither PKC
(Figure 7A) nor CD28 (Figure 7B) accumulation at the be unique for CTLA-4.
T cell-APC interface was affected by the reduced quality
of TCR signals generated by weak agonist peptides.
However, CTLA-4 translocation to the surface was sen- Discussion
sitive to variations in the strength of the TCR signal
(Figure 7C). While both agonist and weak agonist pep- The intracellular retention of CTLA-4 suggests that its
trafficking may play a role in regulating its function astides were capable of polarizing CTLA-4 to a position
facing the T cell-APC contact site, agonist peptides were an inhibitor of T cell activation. This idea is supported
by the conserved amino acid sequence of the CTLA-4more efficient at inducing translocation to the immuno-
logical synapse. To more clearly define this observation, cytoplasmic region among many mammalian species,
indicating that its ability to interact with other proteins,images were captured from experiments in which cells
were stained with antibodies specific for mouse immu- such as those involved in clathrin-mediated endocyto-
sis, may be essential to its function. Different expressionnoglobulin to distinguish the B cell membrane from the
T cell membrane. The images shown in Figure 7D illus- and trafficking patterns between CD28 and CTLA-4 are
potentially important for regulating the balance betweentrate the differences in the localization patterns of
CTLA-4 between strong agonist and weak agonist stim- the activating and inhibitory signals respectively gener-
ated by these two proteins. While CD28-mediated co-ulated cells. Cells stimulated with an agonist peptide
show CTLA-4 staining that appears in contact with the stimulatory signals may be generated constitutively dur-
ing T cell-APC interactions, CTLA-4-mediated inhibitorymouse Ig staining of the APC surface, whereas cells
stimulated with a weak agonist peptide show CTLA-4 signals may be restricted to specific activation condi-
tions due to its unique protein trafficking properties.staining that appears primarily near the MTOC inside
the T cell. We have investigated the localization patterns of
CD28 and CTLA-4 in activated T cells both in the pres-In order to quantify protein translocation induced by
stimulation with different peptides, we examined large ence and absence of TCR stimulation. In a migrating T
lymphocyte, the majority of CTLA-4 protein is localizednumbers of cell conjugates (Figure 7E). Because the
proteins of interest were endogenously expressed by in near the MTOC and its levels in the cell are highly depen-
dent on new protein synthesis. We demonstrate thatvitro stimulated primary T cells, the levels of CTLA-4
and CD28 within the population of activated cells were upon antigen-specific contact between a T cell and an
APC, accumulation of CTLA-4 at the immunological syn-heterogeneous. This made quantifying translocation dif-
ficult because translocation events could not be scored apse is proportional to the strength of the TCR stimulus.
Thus, intracellular retention of CTLA-4 may serve aswhen protein expression was below our limit of detec-
tion. Consequently, only cell conjugates containing a checkpoint to spatially and temporally regulate the
generation of inhibitory signals during T cell activation.T cells that had reorganized their MTOC and that ex-
and a nuclear stain in blue. Images were acquired using a 63 objective. T cells are in the upper half of all images.
(D) Cells were processed as in (A) and stained with antibodies specific for tubulin, mouse immunoglobulin, and CD28 or CTLA-4. Images were
acquired using a 100 objective. T cells are in upper half of all images.
(E) Cells were processed as in (A) and scored for protein translocation into the synaptic region juxtaposed to the APC membrane. Only cell
conjugates that had reorganized their MTOC and that had visibly detectable levels of the protein of interest were analyzed for translocation.
For CD28 and PKC, conjugates were assessed for an increase in brightness at the T cell-APC interface. For CTLA-4, conjugates were
examined for the presence of fluorescent staining at the T cell-APC interface that followed the conformation of the T cell membrane and
appeared distinct from intracellular fluorescence. Cells were examined using a 63 objective. At least three experiments for each condition
were performed blind. Open circles represent values from individual experiments and closed circles represent the average of these values.
Numbers to the right of the graphs represent the total numbers of cell conjugates that were scored for protein translocation from the multiple
experiments.
Immunity
32
Dynamic Nature of CTLA-4 Protein Expression cium fluxes than weak agonist peptides (Wulfing et al.,
1997) and may therefore be more efficient at recruitingin Activated T Cells
While it is known that CTLA-4 is rapidly upregulated CTLA-4 to the immunological synapse. Another possibil-
ity is suggested by the observation that CTLA-4 endocy-upon TCR signaling, the fate of this newly synthesized
protein has been unclear. Our finding that CTLA-4 has tosis is inhibited by tyrosine phosphorylation of its AP2
binding site (Bradshaw et al., 1997; Shiratori et al., 1997).a half-life of approximately 2 hr suggests that gene tran-
scription and translation can be a major factor in de- This may provide a mechanism whereby TCR-mediated
protein tyrosine kinase activity enhances the surfacetermining the precise kinetics of CTLA-4 function. Levels
of CTLA-4 within a T cell will be proportional to its rate stabilization of CTLA-4, thus increasing the expression
of functionally relevant receptors. Weak agonist signalsof protein synthesis, suggesting that arrest of gene ex-
pression may be a method of quickly downmodulating that induce lower or altered kinase activity (Rabinowitz
et al., 1996; Kersh et al., 1998) may be less effective atCTLA-4-mediated inhibitory signals. Given that naive
CD4 T cells require at least 16 hr in the presence of phosphorylating the intracellular tail of CTLA-4 and thus
less effective at stabilizing its expression on the cellan antigenic stimulus for commitment to proliferation
(Iezzi et al., 1998), the levels of CTLA-4 within a cell surface at the immunological synapse.
Our findings concerning the differential translocationcould be adjusted based on signals generated during
the initial interactions of a T cell with an APC. Altering of CTLA-4 demonstrates that the composition of the
immunological synapse can be determined by the qual-the expression levels of CTLA-4 could then impact its
availability at the immunological synapse. This is in con- ity of the TCR signal. Generalizing this concept, it is
possible that individual proteins have an intrinsic TCRtrast to CD28, which due to its slower rate of turnover
would persist within the cell even if gene expression signaling threshold for retention at the T cell-APC inter-
face. Therefore, TCR signal strength may establish ahad been attenuated. Importantly, turnover of both CD28
and CTLA-4 may be modulated upon T cell-APC encoun- hierarchy of protein recruitment to the immunological
synapse. A TCR-based mechanism to modulate theters. TCR signaling as well as engagement with B7 could
significantly alter the half-life of these proteins, thereby composition of the immunological synapse would pro-
vide a means to selectively activate and/or maintainadding another regulatory mechanism for controlling
protein expression levels. specific T cell signaling pathways.
Our findings do not support the notion that a continu-
ally recycling pool of CTLA-4 is present that can rapidly TCR Regulation of CTLA-4-Mediated Inhibition:
mobilize to inhibit a T cell response upon stimulation. From the Single Cell to the Population
While CTLA-4 has been shown to cycle between an Differential regulation of T cells based on TCR signal
intracellular compartment and the plasma membrane strength has important consequences for an antigen
(Linsley et al., 1996), given the rapid turnover rate of specific T cell response. Because the response to a
CTLA-4 that we have observed, it is unlikely that an given antigen is composed of multiple clonal subsets
individual molecule travels repeatedly to and from the of T cells, each with distinct TCR-peptide/MHC binding
surface of the cell. kinetics, a spectrum of TCR affinities exists in the pool
of responding cells. During the course of an immune
response, the diversity of a responding pool of T cells isTrafficking of CTLA-4 during T Cell-APC Interactions
Upon cytoskeletal polarization of the T cell toward an narrowed due to the selective expansion of cells bearing
optimally reactive TCRs (Busch et al., 1998; McHeyzer-antigenic stimulus, the bulk of CTLA-4 is positioned be-
neath the T cell-APC contact site in the cytoplasm. We Williams et al., 1999). Thus, antigen-driven selection
leads to an enrichment of cells bearing TCRs havinghave demonstrated that translocation of CTLA-4 to the
immunological synapse is favored under conditions higher affinities and slower disassociation rates for pep-
tide/MHC (Busch and Pamer, 1999; Savage et al., 1999).when the T cell is receiving signals generated by more
potent TCR-peptide/MHC interactions. The ability of We have previously proposed a model suggesting
preferential CTLA-4-mediated inhibition of T cells bear-strong agonist peptides to more efficiently localize
CTLA-4 to the immunological synapse could be a result ing higher affinity TCRs for a given peptide/MHC ligand
(Kuhns et al., 2000; Chambers et al., 2001). This preferen-of increasing both the polarization of intracellular
CTLA-4 and its subsequent translocation to the T cell tial restriction would allow for greater representation of
cells bearing lower affinity TCRs, and therefore a greatersurface. Given the finding that varying TCR signal
strengths are equally capable of reorganizing the T cell diversity in the T cell response. Attenuation of affinity
maturation in order to maintain diversity in the T cellmicrotubule cytoskeleton, we speculate that stronger
TCR signals have an increased capacity to translocate response may at first seem counterintuitive, but could
serve several important functions. First, T cells bearingCTLA-4 to the T cell surface from a polarized intracellular
compartment. lower affinity TCRs may exhibit greater crossreactivity to
similar antigenic epitopes. In this scenario, maintainingThe mechanism by which CTLA-4 differentially local-
izes to the immunological synapse depending on TCR T cell diversity could improve the ability of the immune
system to respond to mutated or heterologous antigenssignal strength is not known. However, two interesting
properties of CTLA-4 may explain this finding. Calcium derived from pathogens. Second, the strength of TCR
signals may dictate the functional nature of the antigen-ionophores, such as ionomycin, upregulate CTLA-4 sur-
face expression by increasing the rate of CTLA-4 export specific response (Kersh and Allen, 1996). For example,
the cytokine expression profile of a particular T cell mayfrom intracellular compartments (Linsley et al., 1996).
Agonist peptides induce stronger, more sustained cal- be determined by the affinity of its T cell receptor for
Regulation of CTLA-4 Localization
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Mice and T Cell Activationpeptide/MHC ligand (Rogers and Croft, 1999; Malherbe
B10.A recombinase activating gene (RAG)-deficient mice homozy-et al., 2000). T cells bearing lower affinity TCRs may
gous for the 5C.C7 TCR (V11V	3) transgene (Taconic) were bredbe needed to generate specific cytokines required to
and maintained in microisolator cages in accordance with the animal
eliminate many of the pathogens encountered by the care and use regulations of UC Berkeley. T cells from these mice
immune system. recognize moth cytochrome C residues 88-103 (MCC) in the context
of H2-I-Ek.A direct correlation between TCR signal strength and
5C.C7 TCR transgenic lymphnode cells were stimulated with 5CTLA-4-mediated inhibition might also contribute to
M MCC peptide plus irradiated (2000rads) B10.A spleenocytes.T cell diversity in the early stages of the response to a
Two days following stimulation, cells were expanded in the presencecomplex set of antigens derived from a pathogen. This
of 30 U/ml recombinant human IL-2 (Chiron) and used for experi-
effect could be important in the elaboration of a protec- ments 3 days later.
tive T cell response. In the absence of the attenuating
effects of CTLA-4, a small number of highly responsive
Protein Turnover Rate Determination
T cells might quickly out-compete clones with weaker Activated 5C.C7 T cell cultures were purified over a Histopaque-
responses to other antigens, thus leading to an oligo- 1119 (Sigma) density gradient to remove dead cells and debris.
or even monoclonal response. This would be of obvious These cells were 
90% CD4V11 as determined by flow cytome-
try. The activated T cells were then placed back into 37C condi-advantage to the pathogen, since mutation of that domi-
tioned media in the presence of 15 g/ml cycloheximide (ICN) and/nant peptide would allow it to avoid T cell-mediated
or 20 mM ammonium chloride (Fisher Scientific). At the indicatedclearance. By diminishing the proliferative advantage of
time points, cells were removed from the incubator and immediately
the optimally responsive clones, CTLA-4 would decrease washed in ice-cold PBS. Cells were then fixed in 2% paraformalde-
but not eliminate their competitive advantage, thus hyde/PBS for 20 min, washed in wash buffer (2%FCS in PBS) plus
keeping more weakly reactive clones in play as the re- 0.3% Saponin (Sigma), and incubated with the appropriate antibod-
ies for 30 min. All staining was performed at 4C. The samples weresponse progresses. Overall, preferential localization of
washed and run on an XL flow cytometer (Beckman/Coulter). 15,000CTLA-4 to the immunological synapse in proportion to
events gated on the forward and side scatter characteristics ofthe strength of TCR stimulation may provide the basis
T cells were collected for all samples and the mean fluorescence
for a previously unrecognized function of the molecule— intensity of the population determined using Elite software (Beck-
restricting the expansion of T cells receiving stronger man/Coulter).
stimulation, and thereby expanding the diversity of a
T cell response. IL-2 Production Assay and Conjugate Formation Analysis
T cell production of IL-2 in response to antigenic stimulation was
Experimental Procedures determined by mixing 105 T cells with an equal number of mitomycin
C-treated CH12.LX B lymphoma cells in round-bottom 96-well plates
Antibodies along with a titration of the indicated peptide. 12 hr later, superna-
The following antibodies were used. ELISA: IL-2 capture antibody tants were harvested and analyzed for IL-2 content using ELISA as
(clone JES6-1A12) and biotinylated IL-2 detecting antibody (clone described (Krummel and Allison, 1996).
JES6-5H4) (Pharmingen) in combination with horseradish peroxi- Conjugate formation assay was performed as described (Schaefer
dase conjugated streptavidin (Jackson Immunoresearch). Flow et al., 1999). In brief, CH12.LX cells were labeled with PKH26 (Sigma)
cytometry: PE-conjugated hamster anti-CTLA-4 (clone UC10- following manufacture’s instructions and pulsed with a titration of
4F10-11), FITC-conjugated hamster anti-CD28 (clone 37.51), FITC- the indicated peptide for 4 hr at 37C. 5C.C7 TCR transgenic T cells
conjugated rat anti-Transferrin Receptor (CD71) (clone C2), were labeled with 0.1 M of CFSE (Molecular Probes) for 10 min at
FITC-conjugate mouse anti-I-Ek (clone 17-3-3) (all from Pharmingen), 37C in Hank’s balanced salt solution (HBSS). T cells were mixed
TriColor-conjugated rat anti-CD4 (clone RM4-5) (Caltag). Micros- at a 1:1 ratio with peptide-pulsed CH12.LX cells in a 96-well round-
copy: Primary antibodies: Goat polyclonal anti-CTLA-4 (C-19), goat bottom plate. Cells were pelleted by centrifugation at 200 g for 3
polyclonal anti-CD28 (M-20), rabbit polyclonal anti-PKC (C-18) (all min and placed in a 37C incubator for 1 hr. Nonspecific cell conju-
from Santa Cruz Biotechnolgies), mouse monoclonal anti--Tubulin gates were disrupted by repeated pipetting prior to analyzing the
(clone DM 1A) (Sigma), Secondary antibodies: Cy3-conjugated don- samples by flow cytometry. 30,000 live-gated events were collected
key anti-goat, Cy5-conjugated donkey anti-mouse, Cy5 conjugated and analyzed. CFSE positive T cells were analyzed for PKH26 fluo-
donkey anti-rabbit, Cy3-conjugated streptavidin, Fab fragment of rescence in order to determine the percent of T cells bound to
rabbit anti-mouse (Jackson Immunoresearch), Alexa488-conju- CH12.LX cells.
gated donkey anti-mouse (Molecular Probes), Biotinylated donkey
anti-rabbit (Amersham/Pharmacia). All secondary antibodies were
CTLA-4 Surface Expression Analysissolid-phase absorbed so as not to recognize primary antibodies
Stimulation-induced CTLA-4 expression was measured by mixingderived from the other animal species used in multiple labeling
5C.C7 TCR transgenic T cells at a 1:1 ratio with CH12.LX cells thatexperiments.
had been pulsed with 10 M of the indicated peptide. Conjugates
were formed as described above. Following incubation, T cell-APC
Synthetic Peptides conjugates were disrupted by vigorous pipetting in ice-cold PBS.
MCC 88-103 (ANERADLIAYLKQATK), the single amino acid mutants For measuring surface levels of CTLA-4, the cells were stained with
Y97F, T102S, and T102N and HB 64-67 (GKKVITAFNEGLK) were antibodies specific for I-Ek, CD4, and CTLA-4 or an isotype control.
synthesized at the University of California at Berkeley, Cancer Re- For measuring total cellular levels of CTLA-4, the cells were first
search Laboratory Microchemical Facility by standard fluorenyl- stained with antibodies specific for I-Ek and CD4, fixed and permeab-
methoxycarbonyl synthesis. Peptides were purified by reverse lized as described above, and subsequently stained with anti-
phase HPLC (99%) and purity was verified by mass spectroscopy. CTLA-4 or an isotype control. Approximately 50,000 live-gated
events were collected. CTLA-4 expression on unconjugated T cells
was measured by analyzing anti-CTLA-4 staining of cells that wereMedia and Cell Culture
All cell culture was performed in RPMI1640 media supplemented negative for I-Ek expression and positive for CD4 expression. CTLA-4
expression values were obtained by subtracting the mean fluores-with 10% fetal calf serum, 2 M L-glutamine, and 100 U/ml penicillin
and streptomycin (all from BioWhittaker), and 2M 2-mercaptoetha- cence intensity of a sample stained with isotype control antibody
from the mean fluorescence intensity of a sample stained withnol (Sigma). All cells were cultured in a 37C humidified incubator
at 5%CO2. CTLA-4-specific antibody.
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GFP Fusion Constructs and Retrovirus T cell survival by enhancing the expression of Bcl-xL. Immunity 3,
87–98.GFP fusion protein constructs were generated using PCR to amplify
the coding sequence of CD28 and CTLA-4 without their stop codons. Bradshaw, J.D., Lu, P., Leytze, G., Rodgers, J., Schieven, G.L., Ben-
This PCR also introduced a 10 amino acid flexible linker sequence nett, K.L., Linsley, P.S., and Kurtz, S.E. (1997). Interaction of the
(2x Ser1Gly4) to the carboxyl terminus of the genes. All PCR products cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated pro-
were cloned into the pEGFPN3 vector (Clontech). Following confir- tein is negatively regulated by tyrosine phosphorylation. Biochemis-
mation by DNA sequencing, the GFP fusion protein constructs were try 36, 15975–15982.
cloned into a mouse stem cell virus (MSCV) retroviral expression
Bromley, S.K., Burack, W.R., Johnson, K.G., Somersalo, K., Sims,
vector (a generous gift from Dr. William Sha, UC Berkeley) (Hawley
T.N., Sumen, C., Davis, M.M., Shaw, A.S., Allen, P.M., and Dustin,
et al., 1994).
M.L. (2001). The immunological synapse. Annu. Rev. Immunol. 19,
Retrovirus was produced by transient transfection of the BOSC
375–396.
23 packaging cell line (ATCC) as described (Pear et al., 1993). T cells
Brunner, M.C., Chambers, C.A., Chan, F.K., Hanke, J., Winoto, A.,were stimulated as described above and infected 4 days later. Infec-
and Allison, J.P. (1999). CTLA-4-mediated inhibition of early eventstion was performed by centrifugation of retroviral supernatants plus
of T cell proliferation. J. Immunol. 162, 5813–5820.2 g/ml polybrene (Sigma) with T cells at 1200 g. T cells were used
Busch, D.H., and Pamer, E.G. (1999). T cell affinity maturation byfor live cell microscopy experiments between 3 and 4 days following
selective expansion during infection. J. Exp. Med. 189, 701–710.infection.
Busch, D.H., Pilip, I., and Pamer, E.G. (1998). Evolution of a complex
Immunofluorescence Staining, Microscopy, T cell receptor repertoire during primary and recall bacterial infec-
and MTOC Reorientation Analysis tion. J. Exp. Med. 188, 61–70.
T cell-APC conjugates were formed by mixing 5C.C7 TCR transgenic Cefai, D., Schneider, H., Matangkasombut, O., Kang, H., Brody, J.,
T cells at a 1:1 ratio with peptide-pulsed CH12.LX cells, centrifuging and Rudd, C.E. (1998). CD28 receptor endocytosis is targeted by
at 500 g for 30 s, and incubating at 37C for 1 hr. Either conjugates mutations that disrupt phosphatidylinositol 3-kinase binding and
(Figures 3 and 6) or T cells alone (Figure 1) were suspended in costimulation. J. Immunol. 160, 2223–2230.
HBSS and adhered to Superfrost plus positive-charge slides (Fisher
Chambers, C.A., Kuhns, M.S., Egen, J.G., and Allison, J.P. (2001).Scientific) for 5 min. Cells were washed in PBS, fixed in PBS/3.7%
CTLA-4-mediated inhibition in regulation of T cell responses: mech-paraformaldehyde for 15 min, and permeablized with PBS/0.15%
anisms and manipulation in tumor immunotherapy. Annu. Rev. Im-Triton X-100 for 3 min. Cells were washed extensively in PBS and
munol. 19, 565–594.blocked with PBS/5% normal donkey serum for at least 2 hr. All
Chuang, E., Alegre, M.L., Duckett, C.S., Noel, P.J., Vander Heiden,antibodies were diluted in PBS. Antigens were stained sequentially
M.G., and Thompson, C.B. (1997). Interaction of CTLA-4 with theby incubating with a primary antibody for 45 min followed by a
clathrin-associated protein AP50 results in ligand-independent en-secondary antibody for 45 min and repeating. Extensive washing
docytosis that limits cell surface expression. J. Immunol. 159,with PBS was performed in between each step. Samples were
144–151.mounted in PBS/50% glycerol using glass coverslips (Fisher Scien-
tific). For staining of T cell-APC conjugates using mouse anti-tubulin, Davis, M.M., and Bjorkman, P.J. (1988). T cell antigen receptor genes
mouse Ig expressed by CH12.LX cells was first blocked using Fab and T cell recognition. Nature 334, 395–402.
fragments of rabbit anti-mouse. In some experiments, CH12.LX cells Davis, M.M., Boniface, J.J., Reich, Z., Lyons, D., Hampl, J., Arden,
were identified by staining these rabbit Fab fragments with a fluoro- B., and Chien, Y. (1998). Ligand recognition by alpha beta T cell
chrome conjugated anti-rabbit antibody. receptors. Annu. Rev. Immunol. 16, 523–544.
For MTOC reorientation analysis T cell-APC conjugates were
Grakoui, A., Bromley, S.K., Sumen, C., Davis, M.M., Shaw, A.S.,formed and processed as described above, staining the cells with
Allen, P.M., and Dustin, M.L. (1999). The immunological synapse: aantibodies specific for tubulin. Conjugates were examined and
molecular machine controlling T cell activation. Science 285,scored for MTOC reorientation as described (Sedwick et al., 1999).
221–227.Cells were observed on a Leica DMIRB/E inverted microscope
Greene, J.L., Leytze, G.M., Emswiler, J., Peach, R., Bajorath, J.,equipped with a 150watt xenon arc lamp (Optiquip) using either a
Cosand, W., and Linsley, P.S. (1996). Covalent dimerization of CD28/63 or a 100 oil immersion objective. For visual data, images
CTLA-4 and oligomerization of CD80/86 regulate T cell costimulatorystacks consisting of between 30 and 40 planes spaced 0.2 m
interactions. J. Biol. Chem. 271, 26762–26771.apart were acquired using a Quantix CCD camera (Roper Scientific).
Slidebook software (Intelligent Imaging Innovations) was used for Gross, J.A., St. John, T., and Allison, J.P. (1990). The murine homolog
both microscope and camera control. Image stacks were digitally of the T lymphocyte antigen CD28: molecular cloning and cell sur-
deconvolved using the nearest neighbor algorithm of Slidebook. face expression. J. Immunol. 144, 3201–3210.
Live cell experiments were performed using a Bioptechs heated Hawley, R.G., Lieu, F.H., Fong, A.Z., and Hawley, T.S. (1994). Versa-
stage system (Bioptechs) set to 37C. CH12.LX cells that had been tile retroviral vectors for potential use in gene therapy. Gene Ther.
pulsed with 10 M of MCC peptide were added to the heated culture 1, 136–138.
dish in HBSS plus 25 mM HEPES buffer. Retrovirally infected T cells
Huang, J., Sugie, K., La Face, D.M., Altman, A., and Grey, H.M.were then added to the culture dish and T cell-APC interactions
(2000). TCR antagonist peptides induce formation of APC-T cellwere observed using a 63 objective. Brightfield and GFP images
conjugates and activate a Rac signaling pathway. Eur. J. Immunol.were acquired approximately every 15 s.
30, 50–58.
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